Baidu-backed Biomap takes on Google’s AlphaFold in AI drug discovery
Multinational Pharmaceutical Firms Now See the Technological Gap Between Biomap and AlphaFold ‘Reversing’ in Biomap’s Favour
Biomap, a biotechnology start-up co-founded by Baidu’s Robin Li Yanhong and backed by the Hong Kong government, claims it has outpaced Alphabet’s AlphaFold in commercialising AI foundation models for drug discovery.